Stay updated on Tagraxofusp in Secondary AML Clinical Trial

Sign up to get notified when there's something new on the Tagraxofusp in Secondary AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tagraxofusp in Secondary AML Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added Study Description and Study Status entries to the record history (dated 2025-12-17) with Revision: v3.3.3. Removed the HHS Vulnerability Disclosure footer link.
    Difference
    0.6%
    Check dated 2025-12-23T21:08:12.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The record history now includes additions of core sections (Eligibility, Outcome Measures, Arms and Interventions, Study Description, Oversight, Study Status, Study Identification) and a title change from 'With or Without Venetoclax' to 'With Venetoclax' for the TAGALONG trial.
    Difference
    0.9%
    Check dated 2025-12-16T19:52:08.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page history shows a new UI revision entry (Revision: v3.3.2) and removal of Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:29:09.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The government funding and operating status notice has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-11-18T07:13:24.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    A new version entry has been added to the Record History with a newer submission date, updating the study status in the history table. This reflects the ongoing updates to the trial record on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2025-11-03T21:22:44.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    12%
    Check dated 2025-10-06T07:00:03.000Z thumbnail image

Stay in the know with updates to Tagraxofusp in Secondary AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tagraxofusp in Secondary AML Clinical Trial page.